ArticleClinical and experimental medicine2026
Development and validation of a risk prediction model and management strategy for red blood cell irregular antibodies a retrospective cohort study of 521 patients.
Liang Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.